MedPath

Optimal Sensing in Atrial Tachyarrhythmia's Study

Not Applicable
Terminated
Conditions
Paroxysmal Atrial Fibrillation
Sick Sinus Syndrome
Interventions
Device: Accent Pacemaker
Registration Number
NCT01074749
Lead Sponsor
Abbott Medical Devices
Brief Summary

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), and the rejection of far field sensing of the far field R-wave (FFRW).

Detailed Description

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal AF and AT and the rejection of far field sensing of the far field R-wave (FFRW). The study aims to evaluate the accuracy of the detection of atrial tachyarrhythmias (ATAs). An improved detection can potentially increase the accuracy of clinical treatment decisions, based on device derived data.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
111
Inclusion Criteria
  • Patients with class I or II pacing indications for Sick Sinus Syndrome with suspected paroxysmal atrial tachyarrhythmias over the last 6 months
  • Signed informed consent
  • Age >18 yrs
Exclusion Criteria
  • Severe valvular heart disease (echocardiogram less than 6 months old)
  • Angina Pectoris class ≥ III
  • Congestive heart failure - NYHA class ≥ III
  • Left Ventricular Ejection Fraction < 35% (less than 6 months old)
  • Hypertrophic Cardiomyopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Optisense leadAccent PacemakerPatients with an Accent pacemaker and an OptiSense atrial lead
Tendril leadAccent PacemakerPatients with an Accent pacemaker and a Tendril atrial lead
Primary Outcome Measures
NameTimeMethod
Number of undersensing of paroxysmal AF and AT from Holter recording.1-3 months
Secondary Outcome Measures
NameTimeMethod
Number and duration of inappropriate mode switches due to FFRW sensing during sinus rhythm.1-3 months

Trial Locations

Locations (1)

Lucas Andreas Ziekenhuis

🇳🇱

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath